Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06083142 · ClinicalTrials.gov registry record · Early Phase 1
Fecal Microbiota Transplant for Autobrewery Syndrome
A Early Phase 1 study of Auto-Brewery Syndrome and Gut Fermentation Syndrome, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06083142 is a Early Phase 1 study of Auto-Brewery Syndrome and Gut Fermentation Syndrome that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06083142, a Early Phase 1 study of Auto-Brewery Syndrome and Gut Fermentation Syndrome, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to study fecal microbiota transplantation(FMT) by oral capsule in people already diagnosed with auto-brewery syndrome (ABS, also known as gut fermentation syndrome). The main question it aims to answer: Is FMT safe and feasible in this syndrome? Participants will 1. have a "gut cleanout" with oral antibiotics and a colon cleanse, similar to that administered before colonoscopy 2. receive five oral doses of fecal transplant capsules over a week 3. be followed for six months for safety and research samples
Conditions Studied
Interventions
- BIOLOGICAL Fecal microbiota transplantation capsules
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-02-14 |
| Est. Completion | 2030-08-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06083142
The ClinicalTrials.gov registry entry for NCT06083142 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Auto-Brewery Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Fecal microbiota transplantation capsules is the first listed.
NCT06083142 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06083142 about?
NCT06083142 is a clinical study titled "Fecal Microbiota Transplant for Autobrewery Syndrome". The goal of this clinical trial is to study fecal microbiota transplantation(FMT) by oral capsule in people already diagnosed with auto-brewery syndrome (ABS, also known as gut fermentation syndrome). The main question it aims to answer: Is FMT safe and feasible in this syndrome? Participants will ...
What is the current status of trial NCT06083142?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2025-02-14. Estimated completion is 2030-08-31.
What conditions does trial NCT06083142 study?
This clinical trial studies the following conditions: Auto-Brewery Syndrome, Gut Fermentation Syndrome.
What interventions are being tested in trial NCT06083142?
The interventions under investigation include: Fecal microbiota transplantation capsules (BIOLOGICAL).
Who is sponsoring clinical trial NCT06083142?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06083142 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.